13-Nov-24 |
Buy |
Eileen Carr |
0.30p | 13,500,000 |
£40,500.00 |
10-Jul-25 |
Buy |
Eileen Carr |
0.21p | 15,000,000 |
£30,990.00 |
10-Feb-25 |
Buy |
Martin Rosser |
0.21p | 3,900,492 |
£7,996.01 |
10-Jul-25 |
Buy |
Robert Smeeton |
0.21p | 3,773,584 |
£7,924.53 |
10-Feb-25 |
Buy |
Martin Rosser |
0.20p | 2,516,881 |
£4,996.01 |
10-Feb-25 |
Buy |
Martin Rosser |
0.20p | 2,519,419 |
£4,996.01 |
10-Feb-25 |
Buy |
Claire Bay |
0.22p | 2,292,302 |
£4,988.05 |
10-Feb-25 |
Buy |
Robert Smeeton |
0.22p | 1,853,568 |
£4,000.00 |
10-Feb-25 |
Buy |
Robert Smeeton |
0.22p | 926,784 |
£2,000.00 |
10-Feb-25 |
Buy |
Robert Smeeton |
0.20p | 1,008,572 |
£2,000.00 |
10-Feb-25 |
Buy |
Robert Smeeton |
0.20p | 1,008,572 |
£2,000.00 |
10-Jul-25 |
Buy |
Claire Bay |
0.21p | 937,759 |
£1,988.05 |
13-Nov-24 |
Buy |
Martin Rosser |
0.30p | 3 |
£0.01 |
16:24 |
104 @ 0.24p |
16:07 |
521,848 @ 0.23p |
16:04 |
178,152 @ 0.23p |
16:04 |
200,000 @ 0.23p |
16:04 |
100,000 @ 0.23p |
CFO |
Robert Smeeton |
CEO |
Martin Rosser |
Top of Page
You are here:
research